← Back to The Daily Signal
A person takes cream from a small jar with their fingertips

Check the ingredient list for phytonadione epoxide, the label name for vitamin K1 oxide.

Shixart1985CC BY 2.0

Illustrative. Not a product containing vitamin K1 oxide.

Skincare

Europe's Cosmetics Safety Panel Says Vitamin K1 Oxide Is Not Safe in Creams at Up to 1 Percent, Citing Allergic Reactions

Vitamin K1 oxide is the kind of ingredient most people only meet on the back of a small, expensive tube. It turns up in products aimed at dark circles and redness. Europe's independent safety panel has now looked at it and could not find enough evidence to call it safe.

Written by Sama Alabed · November 19, 2026

The short version

What the committee concluded

The Scientific Committee on Consumer Safety, the panel that advises the European Commission on cosmetic ingredients, adopted its preliminary opinion on November 4 and published it on November 5, reference SCCS/1690/26. Its conclusion is that vitamin K1 oxide is not safe when used in cosmetics at concentrations up to 1 percent.

The committee said there is clear evidence, from several case reports in the published literature and from reported serious undesirable effects, that the ingredient can cause serious allergic skin reactions that often need medical treatment. It also said a risk of genetic damage cannot be excluded, and that the data supplied were not enough to set any safe concentration.

Why this ingredient is being asked about

can cause serious allergic skin reactions that often need medical treatment

Plain vitamin K1, phytonadione, has been banned in EU cosmetics since 2009, when Commission Directive 2009/6/EC added it to the list of prohibited substances because it may cause skin allergy. According to a legal analysis of the new opinion, the oxide form had been used as an alternative in eye and redness creams; that product context comes from a secondary source, not from the committee's own summary.

What happens next

A preliminary opinion goes out for comment. Companies can submit more data until January 11, 2027. The committee then issues a final opinion, and the European Commission decides whether to restrict or ban the ingredient. None of that has happened yet, and the opinion has no legal force in the United States.

Honest caveat

This is a preliminary opinion, open for comment, not a regulation. It applies to the EU's assessment process and does not change rules in other countries. The products the oxide appears in come from a legal blog, not from the official summary we read.

What this means for you

If you use an eye cream or redness product, check the ingredient list for phytonadione epoxide or vitamin K1 oxide. Europe's safety panel cites documented cases of serious allergic skin reactions and could not confirm the ingredient is safe at the levels used.

If a product with this ingredient has ever caused itching, redness or a rash around your eyes, that is a good reason to stop using it and mention it to a dermatologist.

Primary sources

  1. European Commission, Scientific Committee on Consumer Safety, preliminary opinion on the safety of phytonadione epoxide (vitamin K1 oxide), SCCS/1690/26, published November 5, 2026

Common questions

Is vitamin K1 oxide banned in Europe now?

No. This is a preliminary scientific opinion that it is not safe at up to 1 percent. The European Commission will decide on any restriction after comments close on January 11, 2027.

Did the committee find it causes harm?

It cited clear evidence from published case reports and reported serious undesirable effects that vitamin K1 oxide can cause serious allergic skin reactions, said a risk of genetic damage cannot be excluded, and found the data insufficient to set any safe concentration.

What names does it go by on labels?

Phytonadione epoxide or vitamin K1 oxide.

Continue readingSkincareThe FDA Just Removed Two Sunscreen Ingredients You Have Probably Never UsedOn September 10, 2026, the FDA issued a final order removing PABA and trolamine salicylate as permitted active ingredients from the US sunscreen monograph, finding that for both the risks outweigh the benefits. PABA can cause allergic reactions and cross sensitize a person to sulfonamide antibiotics, thiazide diuretics, and local anesthetics like benzocaine. Trolamine salicylate carries anticoagulant and salicylate toxicity risks. The FDA says it is not aware of any currently marketed US sunscreen containing either ingredient, and the order does not take effect until September 11, 2027, so there is no action for a reader to take today.Read the story
SkincareCosmetic SafetyVitamin KEU RegulationIngredients

#Skincare#CosmeticSafety#VitaminK#EURegulation#SkincareIngredients

Stay Curious.

Better health isn't found in a single article. It's built through curiosity, evidence, and small discoveries over time. Join thousands exploring longevity, gut health, recovery, nutrition, and the tools that truly make a difference.